May 30, 2025

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 341% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) a compelling opportunity given its potential for significant upside. With a market..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 25% Potential Upside in the Health Information Services Sector

Definitive Healthcare Corp. (NASDAQ: DH) stands as a key player in the healthcare sector, providing a comprehensive software-as-a-service (SaaS) platform that delivers valuable commercial intelligence to..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 345% Potential Upside in the Biotech Sector

Kura Oncology, Inc. (NASDAQ: KURA) has emerged as a compelling player in the biotechnology sector, primarily focusing on developing targeted cancer therapies. With a market capitalization..

Embecta Corp. (EMBC): Investor Outlook with a Promising 69.78% Potential Upside

Embecta Corp. (EMBC), a company deeply rooted in the healthcare sector, specializes in medical instruments and supplies. Founded in 1924 and based in Parsippany, New Jersey,..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a Potential 313% Upside

For investors seeking opportunities in the biotechnology sector, AbCellera Biologics Inc. (NASDAQ: ABCL) presents an intriguing prospect. With a market capitalization of approximately $608.91 million, this..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Report: Navigating Challenges with a 13.10% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a pioneering player in the biotechnology sector, has garnered attention for its innovative approach to cell programming. Despite facing some..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Insights into Growth Potential and Market Position

Fulgent Genetics, Inc. (NASDAQ: FLGT), operating within the dynamic healthcare sector of diagnostics and research, presents an intriguing opportunity for investors looking to capitalize on the..

CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator with 82% Upside Potential

CeriBell, Inc. (CBLL), a medical technology company specializing in cutting-edge neurology solutions, is positioned at the intersection of healthcare innovation and investment opportunity. Headquartered in Sunnyvale,..

Tectonic Therapeutic, Inc. (TECX): Unpacking a Promising 269% Upside Potential

In the dynamic landscape of biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out with its innovative approach to drug discovery and development. This Watertown, Massachusetts-based company..

Fortrea Holdings Inc. (FTRE) Valuation Insights: A 61.98% Potential Upside Amidst Challenging Metrics

Fortrea Holdings Inc. (NASDAQ: FTRE), a notable player in the biotechnology sector, is capturing investor attention with a significant potential upside despite facing some challenging financial..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unveiling a 217% Potential Upside in the Biotech Arena

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector with an impressive 217% potential upside, as suggested by analysts. Headquartered in Cambridge, Massachusetts,..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Growth and Investor Potential

LifeMD, Inc. (NASDAQ: LFMD) is making significant strides within the telehealth sector, a rapidly expanding segment of the healthcare industry. With a current market cap of..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Assessing the 25.96% Potential Upside

Sage Therapeutics, Inc. (NASDAQ: SAGE), a prominent player in the biotechnology sphere, is currently making waves in the healthcare sector with its focus on developing innovative..

AxoGen, Inc. (AXGN) Investor Outlook: Exploring a Promising 124% Potential Upside

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its promising potential upside of 124.12%...

Savara, Inc. (SVRA) Stock Analysis: A Biotech Prospect with a 271% Potential Upside

For investors eyeing the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) represents a compelling opportunity, particularly for those interested in companies focusing on rare respiratory diseases. With..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges for Potential Growth in Healthcare

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, particularly in the medical care facilities industry, provides essential home health and hospice services across the..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotechnology Innovator with a Stunning 221% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector. With a market capitalization of $418.34..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a 50% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI), a venerable name in the healthcare sector with roots dating back to 1882, presents a complex yet intriguing case for..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking the 140% Potential Upside in the Biotechnology Space

Septerna, Inc. (NASDAQ: SEPN) is drawing significant attention from the investor community, given its promising potential upside of 140.03%. As a clinical-stage biotechnology company, Septerna offers..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Uncovering a 41% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is captivating investors’ attention with a notable potential upside of over 41%, according to recent analyst ratings. As a specialty pharmaceutical..

Search

Funds

May 30, 2025

Search

Funds

May 30, 2025

FTSE 100

Funds